Stonebridge Financial Group (Pennsylvania)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.67M Buy
38,063
+153
+0.4% +$35.7K 0.73% 37
2026
Q1
$9.27M Buy
37,910
+160
+0.4% +$37.3K 0.76% 34
2025
Q4
$7.81M Buy
37,750
+81
+0.2% +$16K 0.67% 37
2025
Q3
$6.98M Sell
37,669
-238
-0.6% -$40.8K 0.62% 41
2025
Q2
$5.79M Buy
37,907
+736
+2% +$113K 0.56% 45
2025
Q1
$6.16M Buy
37,171
+3,860
+12% +$604K 0.66% 36
2024
Q4
$4.82M Buy
+33,311
New +$5.16M 0.53% 46

Other funds holding JNJ

Stonebridge Financial Group (Pennsylvania)'s JNJ Position: Q2 2026 in Review

Stonebridge Financial Group (Pennsylvania) increased its Johnson & Johnson (JNJ) stake by 0.4% in Q2 2026, buying an estimated $35.7K and bringing the position to 38,063 shares worth $9.67M. The position accounts for 0.73% of the portfolio, ranked #37.

Stonebridge Financial Group (Pennsylvania) first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,118 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Stonebridge Financial Group (Pennsylvania) held 38,063 shares of Johnson & Johnson worth $9.67M as of Q2 2026.
  • Stonebridge Financial Group (Pennsylvania) bought 153 Johnson & Johnson shares in Q2 2026, an estimated $35.7K.
  • Johnson & Johnson made up 0.73% of Stonebridge Financial Group (Pennsylvania)'s portfolio in Q2 2026, its #37 holding.
  • Stonebridge Financial Group (Pennsylvania) first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,118 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Stonebridge Financial Group (Pennsylvania)'s 13F filing for Q2 2026, filed 6 Jul 2026.